Emergent BioSolutions (EBS) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.67 +5.21%
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
SFBC, KSBI, PVBK, More
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $307.5 million versus the consensus estimate of $283.57 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- EXL (EXLS) Tops Q3 EPS by 6c; offers guidance
- Christopher & Banks (CBK) Tops Q3 EPS by 79c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
